Biodegradable Polymers for Orthopedic Applications: Synthesis and Processability of Poly (l-Lactide) and Poly (Lactide-co-€-Caprolactone)

The synthesis of poly(l-lactide) (PLLA), poly(l-lactide-co-e-caprolactone), and poly(DL-lactide-co-e-caprolactone) by ring-opening bulk polymerization was investigated. Polymerization temperature had a significant effect on the PLLA molecular weight. At 184°C a polymer with a molecular weight of only 10 × 104 resulted. This was lower by a factor of 2 than that obtained at 103 and 145°C. The stannous octoate (SnOct) concentration, with a monomer/SnOct molar ratio in the range of 1,000 to 10,000, was not found to have a significant effect on the PLLA molecular weight. A heterogeneous structure in polymerized PLLA was observed. The intrinsic viscosity of poly(lactide-co-€-caprolactone), obtained at 130°C, monomer/SnOct molar ratio 5,000, and polymerization time of 30 hours, decreased with increasing €-caprolactone content within the first 9 wt% and then leveled off. Die-drawing of PLLA cylinders, for the purpose of increasing the polymer's mechanical strength, was unsuccessful due to the brittleness of the polymer. The drawability of poly(l-lactide), however, was greatly improved by copolymerization with €-caprolactone. With only 3 wt% of €-caprolactone, for example, the tensile strength of die-drawn poly(l-lactide-co-e-caprolactone) was increased by a factor of more than 3. Polymer processing temperature was also investigated. The requirement for low processing temperatures in melt manufacture of controlled release matrix devices containing thermal sensitive drugs was accomplished by three methods: through the use of low molecular weight poly(DL-lactide), adding (DL-lactic) acid oligomer to high molecular weight PDLLA, and copolymerizing DLLA with €-caprolactone. The glass transition temperatures of the modified high molecular weight PDLLA decreased significantly. Melt extrusion below 100°C could be performed.